1. Saunders CD. Parkinson's Disease: A New Hope. 2000. Boston, MA: Harvard Health Publications.
2. Marttila RJ, Rinne UK. Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand. 1976. 53:81–102.
Article
3. Den Oudsten BL, Van Heck GL, De Vries J. Quality of life and related concepts in Parkinson's disease: a systematic review. Mov Disord. 2007. 22:1528–1537.
Article
4. Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR. NMSS Validation Group. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease. Mov Disord. 2011. 26:399–406.
Article
5. Qin Z, Zhang L, Sun F, Fang X, Meng C, Tanner C, et al. Health related quality of life in early Parkinson's disease: impact of motor and non-motor symptoms, results from Chinese levodopa exposed cohort. Parkinsonism Relat Disord. 2009. 15:767–771.
Article
6. Uitti RJ. Treatment of Parkinson's disease: focus on quality of life issues. Parkinsonism Relat Disord. 2012. 18:Suppl 1. S34–S36.
Article
7. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing. 1997. 26:353–357.
Article
8. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995. 4:241–248.
Article
9. Bushnell DM, Martin ML. Quality of life and Parkinson's disease: translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res. 1999. 8:345–350.
10. Martínez-Martín P, Frades Payo B. The Grupo Centro for Study of Movement Disorders. Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. J Neurol. 1998. 245:Suppl 1. S34–S38.
Article
11. Tsang KL, Chi I, Ho SL, Lou VW, Lee TM, Chu LW. Translation and validation of the standard Chinese version of PDQ-39: a quality-of-life measure for patients with Parkinson's disease. Mov Disord. 2002. 17:1036–1040.
Article
12. Katsarou Z, Bostantjopoulou S, Peto V, Alevriadou A, Kiosseoglou G. Quality of life in Parkinson's disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res. 2001. 10:159–163.
13. Luo W, Gui XH, Wang B, Zhang WY, Ouyang ZY, Guo Y, et al. Validity and reliability testing of the Chinese (mainland) version of the 39-item Parkinson's Disease Questionnaire (PDQ-39). J Zhejiang Univ Sci B. 2010. 11:531–538.
Article
14. Hughes AJ, Daniel SE, Lees AJ. The clinical features of Parkinson's disease in 100 histologically proven cases. Adv Neurol. 1993. 60:595–599.
15. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord. 1992. 7:2–13.
Article
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967. 17:427–442.
Article
17. Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease. The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations. Mov Disord. 2003. 18:738–750.
18. Kang Y, Na DL, Hahn S. A validity study on the Korean Mini-Mental State Examination (K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997. 15:300–308.
19. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991. 14:540–545.
Article
20. Chaudhuri KR, Martinez-Martin P, Brown RG, Sethi K, Stocchi F, Odin P, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Mov Disord. 2007. 22:1901–1911.
Article
21. Soh SE, Morris ME, McGinley JL. Determinants of health-related quality of life in Parkinson's disease: a systematic review. Parkinsonism Relat Disord. 2011. 17:1–9.
Article
22. Carod-Artal FJ, Martinez-Martin P, Vargas AP. Independent validation of SCOPA-psychosocial and metric properties of the PDQ-39 Brazilian version. Mov Disord. 2007. 22:91–98.
Article
23. Chapuis S, Ouchchane L, Metz O, Gerbaud L, Durif F. Impact of the motor complications of Parkinson's disease on the quality of life. Mov Disord. 2005. 20:224–230.
Article
24. Chrischilles EA, Rubenstein LM, Voelker MD, Wallace RB, Rodnitzky RL. Linking clinical variables to health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord. 2002. 8:199–209.
Article
25. Gómez-Esteban JC, Zarranz JJ, Lezcano E, Tijero B, Luna A, Velasco F, et al. Influence of motor symptoms upon the quality of life of patients with Parkinson's disease. Eur Neurol. 2007. 57:161–165.
Article
26. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951. 16:297–334.
Article
27. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry. 2000. 69:308–312.
Article
28. Schrag A, Selai C, Mathias C, Low P, Hobart J, Brady N, et al. Measuring health-related quality of life in MSA: the MSA-QoL. Mov Disord. 2007. 22:2332–2338.
Article
29. Schrag A. Quality of life and depression in Parkinson's disease. J Neurol Sci. 2006. 248:151–157.
Article
30. Muslimovic D, Post B, Speelman JD, Schmand B, de Haan RJ. CARPA Study Group. Determinants of disability and quality of life in mild to moderate Parkinson disease. Neurology. 2008. 70:2241–2247.
Article
31. Qin Z, Zhang L, Sun F, Liu H, Fang X, Chan P, et al. Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort. Clin Neurol Neurosurg. 2009. 111:733–737.
Article
32. Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. Quality of life in Parkinson's disease: the relative importance of the symptoms. Mov Disord. 2008. 23:1428–1434.
Article
33. Winter Y, von Campenhausen S, Gasser J, Seppi K, Reese JP, Pfeiffer KP, et al. Social and clinical determinants of quality of life in Parkinson's disease in Austria: a cohort study. J Neurol. 2010. 257:638–645.
Article
34. Hagell P, Whalley D, McKenna SP, Lindvall O. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord. 2003. 18:773–783.
Article
35. McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994. 32:40–66.
Article